Single‐stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non‐randomized, open‐label and exploratory clinical trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|22|12|825-830

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.22, Iss.12, 2015-12, pp. : 825-830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ziconotide Trialing by Intrathecal Bolus Injections: An Open‐Label Non‐Randomized Clinical Trial in Postoperative/Posttraumatic Neuropathic Pain Patients Refractory to Conventional Treatment

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 18, Iss. 5, 2015-07 ,pp. : 404-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

By Choi Seong Hye   Park Kyung Won   Na Duk L.   Han Hyun Jeong   Kim Eun-Joo   Shim Yong S.   Lee Jae-Hong    

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1375-1383

Informa Healthcare

Access to resources Recommend Favorite

A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children

By Cañete Roberto   Escobedo Angel A.   González Maria Elena   Almirall Pedro   Cantelar Nereyda  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2131-2136

Informa Healthcare

Access to resources Recommend Favorite

A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 2016-2024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty‐Five Years or Older: Results of a Multicenter, Open‐Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide–Based Induction Therapy

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 4, 2015-04 ,pp. : 1117-1127

John Wiley & Sons Inc

Access to resources Recommend Favorite